Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts
- 17 November 2023
- journal article
- research article
- Published by Elsevier in International Journal of Drug Policy
- Vol. 122, 104252
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Drug Abuse (1UG1DA050067-01)
- National Institute on Drug Abuse (K23DA049953)
This publication has 36 references indexed in Scilit:
- Understanding the use of diverted buprenorphineDrug and Alcohol Dependence, 2018
- Physician prescribing of opioid agonist treatments in provincial correctional facilities in Ontario, Canada: A surveyPLOS ONE, 2018
- The Prison Economy of Needles and Syringes: What Opportunities Exist for Blood Borne Virus Risk Reduction When Prices Are so High?PLOS ONE, 2016
- Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trialThe Lancet, 2015
- Consistency in Self-Reports of Drug Use Frequency by High-Risk Offenders Over a 5-Year IntervalThe Prison Journal, 2013
- 'Diversion’ of methadone or buprenorphine: 'harm’ versus 'helping’Harm Reduction Journal, 2013
- Perceptions and Influences of a State Prison Smoking BanJournal of Correctional Health Care, 2012
- Exploring prison buprenorphine misuse in the United Kingdom: A qualitative study of former prisonersInternational Journal of Prisoner Health, 2009
- Violent and disruptive behavior among drug‐involved prisoners: Relationship with psychiatric symptomsBehavioral Sciences & the Law, 2008
- Diffusion of Innovations in Service Organizations: Systematic Review and RecommendationsThe Milbank Quarterly, 2004